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Abstract
Background: Trials frequently encounter difficulties in recruitment, but evidence on effective recruitment methods in 
primary care is sparse. A robust test of recruitment methods involves comparing alternative methods using a 
randomized trial, 'nested' in an ongoing 'host' trial. There are potential scientific, logistical and ethical obstacles to such 
studies.
Methods: Telephone interviews were undertaken with four groups of stakeholders (funders, principal investigators, 
trial managers and ethics committee chairs) to explore their views on the practicality and acceptability of undertaking 
nested trials of recruitment methods. These semi-structured interviews were transcribed and analysed thematically.
Results: Twenty people were interviewed. Respondents were familiar with recruitment difficulties in primary care and 
recognised the case for 'nested' studies to build an evidence base on effective recruitment strategies. However, 
enthusiasm for this global aim was tempered by the challenges of implementation. Challenges for host studies 
included increasing complexity and management burden; compatibility between the host and nested study; and the 
impact of the nested study on trial design and relationships with collaborators. For nested recruitment studies, there 
were concerns that host study investigators might have strong preferences, limiting the nested study investigators' 
control over their research, and also concerns about sample size which might limit statistical power. Nested studies 
needed to be compatible with the main trial and should be planned from the outset. Good communication and 
adequate resources were seen as important.
Conclusions: Although research on recruitment was welcomed in principle, the issue of which study had control of 
key decisions emerged as critical. To address this concern, it appeared important to align the interests of both host and 
nested studies and to reduce the burden of hosting a recruitment trial. These findings should prove useful in devising a 
programme of research involving nested studies of recruitment interventions.
Background
Recruitment to studies such as randomized trials is tradi-
tionally seen as highly problematic [1], and trials in pri-
mary care are no exception [2]. Indeed, primary care
researchers encounter particular difficulties because of
the need to engage clinicians working in dispersed set-
tings, where patients attend intermittently and where
there is limited time and multiple competing priorities.
Even experienced researchers are often uncertain how
best to motivate primary care patients and professionals
to participate [3]. Recent years have seen advances in our
understanding of the recruitment process [4], the barriers
that exist [5], and the psychological and social mecha-
nisms which are involved in the decision to participate in
a trial and contribute to research [6-8]. Despite these
developments, rigorous evidence concerning the best
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The Cochrane CENTRAL database of controlled trials
includes many thousands of records, but recent system-
atic reviews of trials of methods of improving recruit-
ment to trials found only limited numbers of relevant
studies [9,10], while reviews of the role of incentives are
equally limited [11]. Much of the literature in this field
reports single 'case studies' investigating whether a par-
ticular method or approach succeeded in the context of a
given trial [12-15]. Factors that are identified as key to
success in trials which have recruited satisfactorily are
often also present in those that have not recruited [16]
which casts doubt on their significance. Recruiting for
science is not underpinned by a science of recruitment.
Like any intervention, a rigorous test of the effective-
ness of a recruitment method is a randomized trial com-
paring one recruitment method with an alternative,
conducted in the context of an ongoing 'host' trial. For
example, Donovan et al randomized men with localized
prostate cancer to see a nurse or surgeon for an 'informa-
tion appointment' in which they were asked to consent to
a trial comparing surgery, radiotherapy, and active moni-
toring. The results showed that there was a small reduc-
tion (4%) in recruitment rate in the group seeing a nurse,
but that the costs of using surgeons were higher [17].
Although some 'nested' trials have been successful, the
relatively small number identified by the published sys-
tematic reviews [9,10] suggests that they are not unprob-
lematic. Indeed, there are a host of potential scientific,
logistical and ethical obstacles. For example, there may be
too few units of analysis available for randomization to
achieve reasonable power. It may be difficult to get inves-
tigators to agree to randomize to different methods, given
that recruitment is such a major issue and a consistent
cause of delay. There may be ethical concerns if different
patient populations are approached in different ways.
Funders may have concerns about the impact of the
nested study on the progress of the host trial. One of the
problems with interpreting the results of single trials of
nested recruitment interventions is that their effect may
be influenced by the context in which the study is done,
and the results of a single nested study may not general-
ize.
Clearly, undertaking nested trials of recruitment meth-
ods presents a major challenge, but the potential rewards
would be high if nested trials contributed to the evidence
base and eased the difficulties in recruitment that most
investigators experience [1,2]. However, at present nested
studies are largely designed and delivered in an ad hoc
way in the context of individual trials, limiting their
impact. Developing a reliable and rigorous evidence base
may require a more systematic approach to conducting
nested trials, involving investigators testing recruitment
interventions across a number of host trials simultane-
ously to maximize sample size and generalizability.
Although a number of potential barriers to nested
recruitment studies are described above, it is not known
if this is comprehensive, and there is no indication of the
relative importance of the different issues. Therefore, we
conducted a study involving key stakeholders working on
the design, delivery and monitoring of primary care trials.
The aim of the study was to explore the perspectives of
stakeholders concerning the acceptability and practicality
of nesting trials of recruitment methods in existing trials.
Methods
We used a qualitative research design, in line with the
Medical Research Council framework for the develop-
ment of trials to evaluate complex interventions [18,19],
because we wanted to explore the scientific, logistical and
ethical considerations that might be relevant to nested
recruitment trials in primary care. We adopted a semi-
structured interview format so that participants could
consider and explain their perspectives on the proposed
approach, but opted to conduct these by telephone to
reduce travel and maximize convenience for participants,
several of whom held senior roles.
Although patients and collaborating clinicians have
important roles in clinical trials, we opted to focus pri-
marily on those involved at an early phase in decisions
about trial design. The key stakeholders were identified
as principal investigators and trial managers, along with
representatives of organisations funding trials and people
serving as ethics committee chairs. We sought to inter-
view around 20 stakeholders from these groups because
we believed that doing so would enable us to include a
reasonable range of perspectives.
Sampling strategy
To identify principal investigators and trial managers we
purposively sampled the National Institute of Health
Research Primary Care Research Network (NIHR PCRN)
portfolio database, which includes all trials receiving
NHS Service Support. We identified current trials and
classified these according to design (i.e. cluster versus
individual), population (routine primary care populations
versus 'special' groups such as adolescents) and interven-
tion type (clinical versus health services research). We
then selected potential informants at random from each
group, randomly selecting an alternative if they declined.
The remainder of our sample was sought from funders
and ethics committees. The major UK public research
funding bodies (Medical Research Council, NIHR Health
Technology Assessment Programme, NIHR Evaluation,
Trials and Studies Coordinating Centre and NIHR Cen-
tral Commissioning Facility) were approached to identify
a senior manager. We contacted the National Research
Ethics Service to identify ethics committee chairs and
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to members of the team from previous research work.
Ethical approval was given by the University of Man-
chester Senate Ethics Committee. Potential respondents
were approached via email and telephone and invited to
take part in a telephone interview. They were asked to
consent to their interviews being audio-recorded.
Interview schedule
Semi-structured interview schedules were devised, with
minor variations to make them relevant to each stake-
holder group. The schedules were piloted with senior
researchers and modified during the project in the light
of experience in the initial interviews. A document
explaining the proposal (i.e. to work with multiple
research teams to test alternative recruitment approaches
across multiple trials) was emailed to participants prior to
interview. The document also outlined potential recruit-
ment interventions, which varied in size, complexity, type
and the resources they might require (Table 1). Inter-
views were conducted by EW. They began with general
questions about primary care research experience and
explored views about recruitment problems (Table 2).
Respondents were then asked to refer to the document
outlining potential recruitment interventions and were
questioned about potential scientific, logistical and ethi-
cal issues.
The interviews were recorded using teleconferencing
facilities, downloaded and sent for 'intelligent' transcrip-
tion (i.e. excluding hesitations and non-verbal expres-
sions). The transcriptions were analyzed thematically
using a pre-determined framework which was derived
from the interview schedule but then adapted and revised
during the analysis [20]. Each transcript was read and
annotated by EW and one other member of the team. Fol-
lowing this, a summary of the data was prepared, and cat-
egorized according to the revised framework. This was
discussed at a meeting of the research team and key
themes were identified. During the course of the analysis,
the researchers compared their interpretations and also
contrasted the perspectives of the different groups of par-
ticipants.
Results
Of 24 people approached, 20 were interviewed: 7 princi-
pal investigators, 6 trial managers, 4 representatives of
funding bodies and 4 ethics committee representatives (3
committee chairs and 1 regional committee officer). One
individual was both a representative of a funding body
and a principal investigator. Three respondents were pre-
viously known to the interviewer. Three declined to par-
ticipate (2 principal investigators and one ethics
committee chair) and one national funding body did not
consider their work relevant to our enquiries.
All informants were knowledgeable about primary care
research recruitment difficulties. Most trial managers
and principal investigators had considerable experience
of research recruitment, usually in primary care settings.
Although the experience of ethics committee and funding
body representatives varied more widely, all had some
primary care experience.
The benefits of nested recruitment interventions
Interviewees were generally receptive to the idea of
researching recruitment interventions and agreed that
researchers often struggled to achieve recruitment tar-
gets. They felt such research could challenge preconcep-
tions and add to the evidence base on recruitment. As a
result, researchers would be able to target resources
where they might be most effective.
'Because you need to find out whether these things
work, and the only way of finding out if they work is
by trialing it, or doing a randomized trial .... It would
be really useful to know the answer to these ques-
tions, whether this actually works.' (Respondent 010,
Trial Manager, TM)
Whilst the knowledge generated through nested
recruitment studies would primarily benefit the wider
research community, interviewees also identified more
immediate benefits which might accrue to the host study.
These included access to new resources and training, as
well as the potential to improve recruitment.
'As a PI, what you'd be thinking about is, was this a lit-
tle bit more resource?... If this was an extra bit of
resource then that would be a huge advantage. The
other advantage would be as with all research ... that
you might actually get an answer to the question
because it's a difficult thing to do and we know it's dif-
ficult; if we thought we were contributing to finding
out ways of making it better, then I think we'd be
delighted.' (017, Principal Investigator, PI)
Several commented that researching recruitment by
conducting nested studies was likely to be cost effective.
The process of conducting such studies would also
prompt the exchange of ideas and collaboration between
research teams.
'You'd maybe get experience of something you hadn't
thought of, an approach that is different from what
you would have thought of putting into the protocol
to begin with.... Advice and involvement with other
triallists and people that might help.' (011, TM)
Issues for host studies
Respondents differentiated between potential disadvan-
tages for host studies and those for the nested trial. Con-
cerns for host studies centred on management burden,
trial complexity, compatibility between the two studies,
and impacts on trial design and relationships with collab-
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patients if the consent process was made more complex.
Organizational burden
Interviewees expressed concerns about study manage-
ment burden, given that managing the host trial was
already challenging. Some voiced concerns about an
additive effect of nested trials and whether additional
procedures would impact on current workload.
'My immediate thought is, it's just one more thing to
remember and to try and keep on top of. I don't know
if you've run a clinical trial, but just keeping a track of
where you're up to with everybody is a nightmare.'
(005, PI)
'Some studies already struggle with being quite com-
plex; fitting something else in depends on how much
it impinges on that study.' (012, PI)
The presence of the additional intervention could also
interact with the host study to compound complexity and
burden.
Table 1: Summary of potential recruitment interventions provided to participants before interview
Unit of Allocation1 Recruitment Stage2 Type of Intervention
Financial incentives to 
patients and professionals 
(e.g. payment for recruitment, 
lottery etc)
Trial, cluster, individual 1, 2, 3, 4 Incentives
Attachment of additional, 
dedicated research nurses for 
sessions in participating 
centres
Trial 2, 3, 4 Resources
Showing a DVD of previous 
trial participants discussing 
their experiences of being 
involved in research.
Cluster, individual 1, 2, 3 Attitudes of patients and 
professionals
Mass media approaches to 
change attitudes to trials 
among patients
Trial 3, 4 Attitudes of patients
Educational incentives to 
clinicians. e.g. seminar on 
trials and research methods
Trial, cluster 1, 2 Attitudes of professionals
Training for clinicians in 
seeking consent for trials
Trial, cluster 2 Attitudes of professionals
Option to refer patients to a 
dedicated research centre or 
hub
Trial, cluster 2 Incentives for professionals
Support for investigators on 
project management and 
monitoring approaches, with 
in-built contingency planning
Trial Trial planning Advice and support for trial 
recruitment
1 Unit of allocation for the recruitment intervention: (Trial, Cluster within a trial, Individual patient)
2 Recruitment stage that intervention is designed to improve:
Trial planning and organization;
Stage 1: Professional consent to participate in trial;
Stage 2: Professional recruitment of patients;
Stage 3: Patient consent to participate in trial;
Stage 4: Retention of patient in trial
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don't they? They complicate things organizationally;
they could complicate things in the sense that if the
nested study goes wrong, what happens to the main
study? What are the implications for the main study?
If there's a major adverse event in the nested study,
what does that mean for the host study?' (003, PI)
Methodological compatibility
The impact of a nested study would also depend on com-
patibility - the degree to which both studies used similar
procedures and criteria.
'I don't really see any [problems] provided it didn't
compromise the design of the original trial set-up. So
provided it could actually be nested within and wasn't
really pushing the boundaries of the inclusion or
exclusion criteria, or the length of recruitment, pro-
vided then it wasn't going to scupper the trial it's
nested in ... As long as the nested design fitted initially
with the particular trial I think it would be fine.' (004,
TM)
Several respondents were concerned about impacts on
the host trial design. Common quality safeguards applied
to trials should also be applied to nested trials.
'There's the whole question of blinding and outcome
assessment and all the rest of it. It's a separate study
so it's a question of making sure that the people deliv-
ering the different interventions are separate from the
outcome assessors and so on.' (001, Funder)
In certain contexts, nesting could subvert the design of
the host trial, by selectively increasing recruitment in one
arm of a trial, or modifying the type of participants
recruited.
'If you have a cluster trial and your cluster size is not
very big, I suppose there is a danger that by doing
your.... well there is a chance that by intervening in
your clusters, you affect recruitment differentially to
different groups, because if the clusters are in effect
the randomized unit and they're not well balanced
across the trial intervention, the additional trial inter-
ventions that you're performing ...might actually
unbalance randomization.' (015, PI)
The particular recruitment interventions discussed are
considered below, but as a general point it was noted that
certain interventions could even reduce recruitment.
'It might be that some of these interventions actually
are not just helpful, but are harmful....I might say
about [travelling to] the dedicated hub: if patients
don't want to do that, it could actually in some places
have an adverse effect on recruitment.' (015, PI)
Relationships with collaborators
If the nested study involved allocating different levels of
resources for recruitment, this could affect relationships
between the study team and clinical collaborators. Also
collaborators who had strong preferences for one recruit-
ment approach might not agree to random allocation.
'Well the first thing that springs to mind is if you get
your GPs together for a meeting and discuss that,
then I could see some going, "Oh, but I only wanted to
have that bit of the study", and - because you even get
it sometimes with double blinds and stuff where
they're going, "But I want that arm of the study," and
you say, "Well, no you can't, we're randomizing it." I
could just imagine potentially there would be rather
more of that: "Well how come they get to see the
DVDs and we have to deal with this bit?".' (002, TM)
'Money is always a difficult thing. Because if you're
paying people - then you potentially may randomize
them to the arm that doesn't pay them - some people
may be less than happy.' (019 PI/Funder)
Impact on participants
Unsurprisingly, the ethics committee chairs had concerns
that the additional complexity of a nested study might
increase the burden on patients, and that this might
impact differently on different patient populations.
'One would need to look again at the health profiles
and social profiles of the participants. So if they're
quite frail, if they've got serious mental health prob-
lems, is this putting an unreasonable burden on
them? Does the outcome overcome the burden or bal-
ance against the burden.' (007, Ethics)
'So I would be perfectly happy for you to go and do it
in different ways, but this needs to be thought about:
what is the framework within which this is being
done, so that you can ensure that no patient is
Table 2: Outline of interview schedule
Past experiences of primary care studies
How decisions on recruitment strategies are made
Barriers to recruitment and potential solutions
Views about feasibility of nested recruitment methods 
interventions:
- Advantages of nesting recruitment interventions
- Disadvantages of nesting recruitment interventions
- Risks to main study of nesting recruitment interventions
- Would it matter what sort of main trial was being 
conducted?
- Would the timing of nested studies matter?
- Discussion of recruitment interventions circulated in 
advance (Table 1)
Topics discussed with subgroups:
- Personal views if asked to nest a recruitment study (PIs)
- Ethical implications (Ethics)
- Would funding body support/incentivize nested studies? 
(Funders)
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it?' (009, Ethics)
Issues for nested recruitment studies
Control of the research
A recurring theme was the concern that the nested study
should not jeopardize the host trial. As a result, although
research on recruitment was seen as useful, this support
was conditional and depended on the particular circum-
stances. If host study investigators or clinical collabora-
tors had strong preferences for one recruitment
approach, this might conflict with the intention of the
nested study to allocate different patients or sites to dif-
ferent conditions. Or, if overall recruitment proved inade-
quate as the study progressed then the priorities of the
host study could override those of the nested study. This
might involve stopping an intervention in one arm, or
shifting additional resources to the poorly performing
arm.
'The trouble is, if your trial is struggling... you need to
do anything you can, so you would then potentially
swamp the effect of any intervention.' (015, PI)
Study design
Participants made a number of comments about the
design of nested methods trials. Essentially, all aspects of
study design needed to be addressed in order to produce
a coherent research plan. For example, it was important
to achieve adequate statistical power in the nested study.
'The difficulties are that if recruitment is your out-
come then you actually need quite large numbers to
see differences between different strategies.' (014,
Funder)
There might also be difficulties in interpreting the out-
comes of nested studies, so including a qualitative ele-
ment would be helpful:
'[You] would have to have a qualitative arm running in
parallel with it; presumably that's what you encourage
as well. So it would inform why certain recruitment
strategies are working or not working. Because some-
times it's something bizarre that makes them work -
not what you think is actually working.' (019 PI/
Funder)
How to nest recruitment interventions
Respondents suggested approaches to the design and
implementation of nested recruitment interventions,
highlighting timing, compatibility, confidence, communi-
cation, planning and resources. Notably, three of the
funders emphasized that they viewed the piloting of
recruitment methods as feasibility work which should
normally be done before a trial began. Thus, although
alternative recruitment methods could be evaluated, it
would be important that they had been shown to be feasi-
ble. This could act as a major obstacle to the acceptance
of nested recruitment interventions.
'I suppose what I am saying is I would be looking for
evidence of feasibility; you know, I would have
thought it should be demonstrated that a triallist can
recruit by the time they come to a large grant.' (014,
Funder)
Timing and resources
When asked whether nested recruitment studies should
be introduced at the inception of the host trial, or as a
'rescue' if the trial encountered difficulties, most opted to
include them from the outset, although a minority pre-
ferred to establish a recruitment baseline first.
'It's better to do it at the beginning when everyone is
signed up to it, that's no question. I think that would
be an advantage.' (012 PI)
'Bringing it in as an amendment in the middle would
create trouble .... Because of the risks and difficulties
and stuff that need to be addressed. Far better to do it
as a package before you start.' (008, Ethics)
'I think it [establishing a baseline first] might have
some advantages statistically, because you could do a
controlled before and after analysis, so you could look
to see whether giving extra education to clinicians
leads to an increase in their recruitment.' (014,
Funder)
It was seen as essential to plan and anticipate the
resources needed for the added work that the nested
study might entail.
'I suppose adequate resourcing in advance is the key,
and being realistic about time frames for getting such
a thing set up. .... Planning always takes longer than
you expect, so I think, yes, enough anticipation of the
time requirements and the resources needed is proba-
bly the key.' (016, TM)
Compatibility and communication
To enable integration there needed to be compatibility
between the main study and the nested one. Respondents
felt that early consultation with stakeholders would facili-
tate this.
'I think for it to work, you have to know that it's the
right design for what you're doing in the context you
are in, know it's well resourced enough to make it
possible and not to jeopardize the main study. ... It's a
very interesting idea if the proposal is one that's plau-
sible and fits with the structure of the study ...' (003,
PI)
'From the funder's perspective or the Programme
Grant's perspective, the programmes need to be
coherent, they need to fit together.... The whole needs
to be based on the sum of the individual parts, and so
the embedding of a nested study needs to be justified
and in an ideal world it should be done at a pre-trial
level.' (014, Funder)
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teams was also considered important to build up trust
and good working relationships.
'...so long as everybody understood the game plan and
understood why it was happening...' (004, TM)
'If you're running your trial then you tend to be very
involved with it and it tends to be your baby to a
degree. You have other people coming in... you have
to have a great level of trust. ... even if it's an indepen-
dent project within a trial, there still has to be excel-
lent liaison.' (019, PI/Funder)
Several of the principal investigators also commented
that they would like recognition for having participated.
One pointed out that if hosting recruitment research was
to be a genuine collaboration, then the best incentive
might be to be able to contribute to authorship:
'Oh, co-author on a Lancet paper and - done!' (020,
PI)
Reactions to potential recruitment interventions
During the interview, specific examples of potential
recruitment interventions were presented to intervie-
wees. Not all interviewees commented on each, but the
key points made are summarized in table 3. A common
theme was that hosts needed to have confidence in the
intervention proposed.
'If recruitment was working or you could see that
[nested approach to] recruitment had been
researched and thought about, was based on evidence
and was going to be successful, I can't see it being a
problem...... if your trial estimated they were going to
be reasonably successful, introducing different meth-
ods within individual clusters would be quite accept-
able.' (011, TM)
Specific recruitment interventions could be problem-
atic. Nested trials of financial incentives provoked strong
reactions, such as this comment from an ethics commit-
tee chair.
'The one that most rings alarm bells is .... financial
incentives and I think we've already discussed that
about the balance between reasonable payment for
reimbursement of expenses and over and above that -
and does that payment become excessive and seen as
an inducement when it may not necessarily be in an
individual's best interest to take part in the study, but
it shifts the balance and their ability to make an
informed consent.' (007, Ethics)
Although some commented that from their experience,
some of the recruitment interventions were beneficial,
and hence not really worth testing, others pointed out
potential disadvantages. For example, attaching a nurse
researcher was felt by some to be an obvious stimulus to
recruitment.
'The dedicated research nurses, again that seems to
me a feasible trial within a trial, although it would
seem to me so obvious that having extra staff would
make a difference that you couldn't really claim too
much equipoise on it; or at least I couldn't. And I
couldn't sell equipoise to the practitioners. ....so I
think it may be self-evident, although I couldn't quote
any evidence for that at all.' (003, PI)
In contrast to this enthusiasm, others raised concerns
that having additional staff coming into a practice might
pose logistic problems or undermine continuity of care.
Similar concerns were raised about whether other poten-
tially beneficial recruitment interventions might increase
the burden on potential participants or clinical collabora-
tors. These are reported in Table 3 and illustrate the
degree of uncertainty about the approaches suggested.
Discussion
The present situation, where nested studies of recruit-
ment methods are conducted on the initiative of individ-
ual investigators, means that there is no systematic
approach to the choice of interventions. This in turn
leads to concerns about the generalizability of findings
beyond the individual trial and a failure to build knowl-
edge about what works best over time. A more ambitious
approach to improving the evidence base is through
development of a portfolio of relevant recruitment inter-
ventions (based on theory and empirical evidence) which
could be offered to investigators for inclusion within an
individual trial, or across multiple trials, using the 'nested'
methodology. If participation in nested studies was
incentivized (using methods similar to those used to
encourage greater public and patient participation in
research), it is possible that a systematic database could
be built of the effectiveness of different recruitment strat-
egies, the variability in their effects, and the sorts of char-
acteristics (of populations, interventions, or contexts)
that moderate their effects. As noted in the introduction,
there is an argument that the complexity of decision mak-
ing about trial participation is such that the impact of any
recruitment intervention will be influenced significantly
by contextual factors, such as preferences for the inter-
ventions under test [21], other incentives in operation
[22] and logistical barriers such as travel and cost [5]. By
nesting recruitment interventions in a number of trials
simultaneously, it would be possible to explore this
hypothesis empirically, and determine whether the pro-
posed approach to improving recruitment is likely to be
fruitful.
What do the current data say about the successful
implementation of such a model? At a very broad level,
there was agreement that nested studies were a positive
idea. This is expected, given the ubiquity of recruitment
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funders and ethics committees would be positive about
research in general. However, it was clear that given even
limited time to consider the idea and some concrete
examples, it was easy for respondents to identify a num-
ber of problems, and we concentrated our analysis on
these challenges.
Representatives from funders gave the impression that
they normally expected recruitment procedures to have
been piloted and problems identified before embarking
on the main study. Clearly, this is an explicit part of the
MRC framework. However such pilots can be victim to
the contextual issue raised above: where pilots are run in
atypical contexts (e.g. enthusiastic practices who are early
adopters of an intervention), the experience and the les-
sons derived may not reflect the response in a wider roll
out. Nevertheless, the idea that nesting recruitment inter-
ventions might clash with the perception that the trial is
viable is clearly a significant barrier.
Table 3: Summary of responses to proposals for nested recruitment studies
Type of intervention Perceived advantages Perceived disadvantages Points to consider in 
implementation
Financial incentives to 
patients and professionals
Worth trying, extra resource; 
straightforward; it is justified 
to pay people for their time
May create ethical dilemmas, 
difficult to set right payment 
level; managing preferences 
may pose problems
May be more acceptable for 
professionals than patients; 
consult widely to set levels; 
avoiding coercion; avoiding 
drop-outs due to preferences?
Attachment of additional, 
dedicated research nurses for 
sessions in participating 
centres
Dedicated extra resource; 
logical; gives continuity within 
the research; creates 
ownership; stimulate interest 
on site
May impact on continuity of 
care; may cause logistical 
problems; more relationships 
to manage
Local input to staff selection; 
consider continuity of care; 
integration in practice; 
contractual issues
Use of DVD of previous trial 
participants discussing their 
experiences of trial 
participation
Worth trying; good idea; visual 
media are attractive; could 
work for lots of trials
Lack of time; unwillingness to 
watch; content may not be 
believed; may over-simplify; 
technical challenges
Mode of delivery, content, 
run-time; whether study 
specific or generic; age group 
biases; Information equity
Mass media approaches to 
change attitudes to trials 
among patients
Very important; good idea; 
may work well in areas with 
high refusal rates; challenge 
notion of 'guinea pig'
Expensive, difficult to focus 
message on local area or topic; 
may not produce immediate 
impact
Cost difficulties, measuring 
impact; avoiding bias
Educational incentives to 
clinicians: e.g. seminar on 
trials and research methods
Others report this works; may 
bring lasting benefit; research 
understanding will motivate 
participation
Lack of time; lack of interest; 
burden; difficult to motivate 
clinicians
Motivating clinicians; clinician 
preferences; how learning 
occurs; training location
Training for clinicians in 
seeking consent for trials
Interesting idea; may lead to 
more positive explanations of 
research; reduce clinician fear
Few studies use clinicians to 
consent patients; lack of time 
and motivation; burden
Assess numbers of studies 
using clinicians to consent; 
motivating clinicians; training 
location; control arm
Option to refer patients to a 
dedicated research centre
Feasible; interesting; 
participants will get more 
information and attention; 
professional
Additional cost and burden of 
travel; data collection and co-
ordination
Defraying travel costs; 
coordinating data
Support for investigators on 
project management, 
monitoring and contingency 
planning
Good idea, but should be in 
place anyway
Difficult to randomize if only 
used by those who want help
Designing to enable 
randomization
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Page 9 of 10Although some points related to scientific issues about
design, the fundamental concerns related to the viability
of the host trial in logistical and administrative terms
when the nested trial was added. Participating in a nested
recruitment study has implications for the time, attention
and enthusiasm of researchers, and it appears that inves-
tigators will be making cost benefit assessments when
deciding whether to participate. The difficulty is that, as
for participants in most clinical trials, the benefits of
nested recruitment studies accrue to the wider scientific
community in the future, whereas the costs fall more
immediately on the research team. This raises the issue of
the importance of specific incentives to increase the per-
ceived benefits of nested trials to their hosts. Clearly,
many recruitment interventions could involve additional
resources (e.g. nurse time, marketing advice, creation of
resources etc) which could function as incentives, even if
no direct financial incentive was in place. However, it is
also clear that nested trials are likely to require additional
resources for both the core research team running the
nested studies and the host studies on which they are run.
A major theme related to issues of control. As noted
previously, many published nested studies have been
designed on the initiative of individual investigators, and
one of the reasons for this is that in such cases they have
control over both host and nested study. Nested studies
conducted as part of a wider research initiative require
that aspects of the design, analysis and write up may be
taken 'outside' the research team (even if there is prelimi-
nary discussion and negotiation prior to adoption of the
nested study). There was a strong suggestion that investi-
gators would want to choose which interventions to test,
and warnings that there could be a clash between the
aims of the host and nested study. For example, if there
was clear evidence from early data that one recruitment
method was superior, it might be difficult to avoid the
temptation to use it with all patients and sites, especially
if overall recruitment is low. Equally, if anecdotal data
suggested that an intervention was alienating collabora-
tors, it might be difficult to continue with the nested
study. Researchers, collaborators and patients within the
host study are active agents, and there were suggestions
that 'resentful demoralisation' [23] might occur in studies
or sites which did not receive a favoured intervention like
a financial incentive.
Limitations of the study
It could be argued that seeking to randomize patients,
professionals or trials to different recruitment interven-
tions ignores the complexity of the recruitment process
and attempts to apply a simplistic model to a complex
area where context may be critical. However, the Medical
Research Council framework that informed this study
would emphasize that the methodology of nesting trials
must be rooted in relevant theory, if the interventions to
be nested are likely to be effective.
One major limitation of the study relates to the omis-
sion of patients. As noted by several respondents, nested
studies may impact on patients, with the potential for
confusion for patients if consent procedures were made
more complex. It could be argued that in many cases
patients will not need to know if they are part of a nested
recruitment study. Indeed, seeking consent to participate
in a trial of recruitment methods might impact on
recruitment itself because simply telling a patient that
they were being randomized to a recruitment incentive
might influence their behaviour. Likewise clinical collab-
orators who are involved in recruitment might react in
complex ways to being told that they were being random-
ized to different recruitment approaches. While we might
have learnt more by including this group within our sam-
ple, we opted not to because our main focus was on the
people directly concerned with designing and managing
trials.
There were a variety of additional methodological limi-
tations. Only a limited range of hypothetical scenarios
were included, so there may be issues specific to certain
types of trials that were not discussed. Although respon-
dents were given information before the interview, not all
had this to hand and they needed to respond quickly to
issues that were raised during discussion. It is possible
that other issues may have arisen after further consider-
ation, or that their attitudes may have changed on subse-
quent reflection. It should be noted that some of the
principal investigators and trials managers may not have
recent experience of direct patient and professional
recruitment. It is possible that the study may have bene-
fited from the use of focus groups, although the logistics
and cost of setting up such groups with dispersed respon-
dents would have been prohibitive. The respondents
from the funding bodies could only provide their per-
sonal perceptions and their views cannot be considered
to reflect the policy of their employing organizations,
although at least one respondent did circulate the inter-
view schedule to a wider group of colleagues for com-
ment. Although we explored differences between the four
groups of respondents, these mainly followed their
expected interests as researchers, funders and ethical
guardians of patients' interests. We therefore concen-
trated on the issues common across groups in the analysis
presented in this paper.
Conclusions
Recruitment difficulties are widespread, and even though
the creation of research networks has provided an infra-
structure to address this, delays are still common and
there are concerns that the small proportion of practices
and patients participating in trials limits the generaliz-
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Page 10 of 10ability of research findings. The current study has dem-
onstrated some cautious support for the idea of nested
studies of recruitment methods, and has provided
insights into the barriers to their implementation. Key
issues for consideration include planning at the earliest
possible stage; working with principal investigators to
ensure compatibility with the host study; and making
sure that communication and relationships are effective.
As with any study, the nested recruitment interventions
must be rigorously developed to ensure findings are
robust and generalisable. Principal investigators may have
preferences about the timing of nested studies, but
whether they begin at the start or after a baseline is estab-
lished for the main study, clear procedures should be put
in place and above all adequately resourced.
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